Cytotoxicity of Amphotericin B and AmBisome: In Silico and In Vivo Evaluation Employing the Chick Embryo Model
Leishmaniasis has been identified as a significant disease in tropical and subtropical regions of the world, with Iran being one of the disease-endemic areas. Various treatments have been applied for this disease, and amphotericin B (Amp B) is the second line of treatment. Side effects of this drug...
Main Authors: | Ahmad Khosravi, Iraj Sharifi, Hadi Tavakkoli, Elaheh Molaakbari, Sina Bahraminegad, Ehsan Salarkia, Fatemeh Seyedi, Alireza Keyhani, Zohreh Salari, Fatemeh Sharifi, Mehdi Bamorovat, Ali Afgar, Shahriar Dabiri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.860598/full |
Similar Items
-
Comparison of cytotoxicity of Miltefosine and its niosomal form on chick embryo model
by: Fatemeh Seyedi, et al.
Published: (2024-01-01) -
The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles
by: Louise Walker, et al.
Published: (2018-03-01) -
Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion.
by: Nath, P, et al.
Published: (2014) -
Synthesis and physicochemical characterization of Zn–Al layered double hydroxides (LDHs) as a delivery system for amphotericin B: In vitro and in silico antileishmanial study
by: Sina Bahraminejad, et al.
Published: (2023-04-01) -
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
by: David S. Lawrence, et al.
Published: (2018-11-01)